Neurological Genetics tests in Dubai & UAE

Compare available Neurological Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,000.00–3,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurological Genetics test prices

Showing 16–30 of 71 matching tests.

Neurological Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4963 CRBN Gene Genetic Test for Autosomal Recessive Mental Retardation Type 2 This test identifies pathogenic variants in the CRBN gene associated with Autosomal Recessive Intellectual Disability Type 2 (MRT2).	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	21–28 days (3–4 weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CRBN gene", "Coding region and splice-site boundaries of the CRBN gene"] Parameters [] Preparation ["Avoid blood transfusions for at least two weeks before phlebotomy."] Indications ["Unexplained moderate to severe intellectual disability", "Family history suggestive of autosomal recessive inheritance", "Carrier testing for at-risk family members", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 103354-1 ICD-10: F78.9, Z14.8, Z84.8 Clinical summary This test identifies pathogenic variants in the CRBN gene associated with Autosomal Recessive Intellectual Disability Type 2 (MRT2).
TEST-4665 CSPP1 Gene (Joubert Syndrome Type 21) Genetic Test This test identifies pathogenic variants in the CSPP1 gene associated with Joubert syndrome type 21.	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3–4 Weeks (21–28 business days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CSPP1 gene", "Point mutations", "Small insertions/deletions", "Copy number variants"] Parameters [] Preparation ["No fasting required", "No alteration of medications required unless advised by physician"] Indications ["Suspected Joubert syndrome type 21", "Confirmation of clinical diagnosis", "Genetic counselling", "Prognostic stratification", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 81260-6 ICD-10: Q04.3 Clinical summary This test identifies pathogenic variants in the CSPP1 gene associated with Joubert syndrome type 21.
TEST-3942 CTDP1 Gene Sequencing (Cataracts, Facial Dysmorphism, Neuropathy Syndrome) Test This test evaluates the CTDP1 gene for variants associated with Congenital Cataracts, Facial Dysmorphism, and Neuropathy syndrome.	Peripheral whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks from sample receipt at sequencing laboratory	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CTDP1 gene variants", "Single nucleotide variants", "Small indels", "Copy number changes"] Parameters [] Preparation ["No fasting required", "Avoid heparin-containing tubes"] Indications ["Suspected CTDP1-related syndrome", "Family history of CCFDN", "Confirmation of molecular diagnosis", "Carrier testing", "Recurrence risk counselling"] Measurement technique Confirm with laboratory Codes LOINC: 21618-3 ICD-10: Q87.0, Q12.0 Clinical summary This test evaluates the CTDP1 gene for variants associated with Congenital Cataracts, Facial Dysmorphism, and Neuropathy syndrome.
TEST-4999 DCC Gene Mirror Movements Type 1 Genetic Test This test detects pathogenic variants in the DCC gene associated with congenital mirror movements disorder.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DCC gene", "SNVs, Indels, CNVs, Splice-Site Variants"] Parameters [] Preparation [] Indications ["Confirmation of diagnosis for congenital mirror movements disorder", "Guiding prognosis", "Informing familial risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 101135-2 ICD-10: G11.8 Clinical summary This test detects pathogenic variants in the DCC gene associated with congenital mirror movements disorder.
TEST-5646 DDHD1 Gene SPG28 Genetic Test This test evaluates the DDHD1 gene for variants associated with autosomal recessive hereditary spastic paraplegia type 28 (SPG28).	Peripheral whole blood, Extracted DNA, or FTA Card Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DDHD1 gene sequence", "Copy Number Variants (CNVs) in DDHD1 gene"] Parameters [] Preparation [] Indications ["Suspected diagnosis of SPG28", "Family history of hereditary spastic paraplegia", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 91809-7 ICD-10: G11.4 Clinical summary This test evaluates the DDHD1 gene for variants associated with autosomal recessive hereditary spastic paraplegia type 28 (SPG28).
TEST-4210 DNM2 Gene DI‑CMTB Next‑Generation Sequencing (NGS) Genetic Test This test detects pathogenic variants in the DNM2 gene associated with Dominant Intermediate Charcot-Marie-Tooth disease type B.	Peripheral whole blood (EDTA) or saliva (Oragene DNA kit)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DNM2 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected diagnosis of Dominant Intermediate Charcot-Marie-Tooth disease type B (DI-CMTB)", "Family history of DI-CMTB", "Need for genetic counseling and risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G60.0 Clinical summary This test detects pathogenic variants in the DNM2 gene associated with Dominant Intermediate Charcot-Marie-Tooth disease type B.
TEST-4249 DOCK7 Gene Early Infantile Epileptic Encephalopathy Type 23 (EIEE23) Genetic Test This genetic test evaluates the DOCK7 gene for pathogenic variants associated with Early Infantile Epileptic Encephalopathy Type 23 (EIEE23).	Peripheral whole blood (EDTA) or dried blood spot (FTA card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DOCK7 gene sequence", "Copy Number Variants (CNVs) in DOCK7"] Parameters [] Preparation [] Indications ["Diagnosis of EIEE23", "Identification of pathogenic variants in the DOCK7 gene"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G40.0 Clinical summary This genetic test evaluates the DOCK7 gene for pathogenic variants associated with Early Infantile Epileptic Encephalopathy Type 23 (EIEE23).
TEST-4195 DRD2 Gene & DYT11-Associated Dystonia NGS Panel Test This diagnostic test evaluates the DRD2 gene and DYT11-associated dystonia locus using Next-Generation Sequencing (NGS). It identifies pathogenic variants linked to hereditary myoc...	Whole Blood (EDTA) or DNA FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DRD2 gene variants", "DYT11 gene variants", "Pathogenic variants in coding sequence and splice sites"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Diagnosis of hereditary myoclonus-dystonia (DYT11)", "Evaluation of dopamine-related movement disorders", "Pharmacogenetic profiling for anti-psychotic or anti-parkinsonian drugs", "Differentiation of hereditary dystonia from sporadic conditions"] Measurement technique Confirm with laboratory Codes LOINC: 69047-9 ICD-10: G24.1 Clinical summary This diagnostic test evaluates the DRD2 gene and DYT11-associated dystonia locus using Next-Generation Sequencing (NGS). It identifies pathogenic variants linked to hereditary myoclonus-dystonia and related movement disorders.
TEST-5926 DRD3 Gene Essential Tremor Type 1 Hereditary DNA Test This diagnostic test evaluates the DRD3 gene for pathogenic variants associated with Essential Tremor Type 1.	Whole blood (EDTA tube), extracted DNA, or dried blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DRD3 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)", "Large deletions"] Parameters [] Preparation [] Indications ["Diagnosis of familial essential tremor", "Genetic confirmation of suspected DRD3-related tremor"] Measurement technique Confirm with laboratory Codes LOINC: 83069-5 ICD-10: G25.0, Z15.89, Z13.858 Clinical summary This diagnostic test evaluates the DRD3 gene for pathogenic variants associated with Essential Tremor Type 1.
TEST-5701 ENTPD1 Gene (SPG64) Next-Generation Sequencing (Genetic Test This test evaluates the ENTPD1 gene for variants associated with hereditary spastic paraplegia type 64.	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ENTPD1 gene sequence", "Pathogenic variants (SNVs, indels, copy-number changes)"] Parameters [] Preparation ["Pre-test genetic counselling session required", "Recent clinical report from a neurologist required"] Indications ["Suspected hereditary spastic paraplegia type 64", "Family history of SPG64", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81664-5 ICD-10: G11.4 Clinical summary This test evaluates the ENTPD1 gene for variants associated with hereditary spastic paraplegia type 64.
TEST-3690 Epilepsy Panel Genetic Test This test evaluates over 200 genes associated with various epileptic syndromes using next-generation sequencing.	Peripheral whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in epilepsy-associated genes", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Continue all medications unless otherwise advised by your physician"] Indications ["Diagnosis of epilepsy syndromes", "Identification of genetic causes in refractory epilepsy", "Pre-symptomatic testing in individuals with a strong family history"] Measurement technique Confirm with laboratory Codes LOINC: 101427-9 ICD-10: G40.9, R56.8, Z86.61 Clinical summary This test evaluates over 200 genes associated with various epileptic syndromes using next-generation sequencing.
TEST-1051 Episodic Ataxia Comprehensive Profile (Hotspot Panel) Test This test identifies pathogenic variants in genes associated with episodic ataxia syndromes types 1 and 2, and related channelopathies.	Peripheral whole blood	3–4 days (sample Monday by 11 am; report Friday)	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in KCNA1 gene", "Pathogenic variants in CACNA1A gene", "Pathogenic variants in related channelopathy loci"] Parameters [] Preparation [] Indications ["Suspected episodic ataxia syndromes types 1 and 2", "Related channelopathies"] Measurement technique Confirm with laboratory Codes LOINC: 81219-7 ICD-10: G11.8 Clinical summary This test identifies pathogenic variants in genes associated with episodic ataxia syndromes types 1 and 2, and related channelopathies.
TEST-4571 FLNA Gene (Periventricular Nodular Heterotopia, X‑Linked Dominant) Genetic Test This genetic test evaluates the FLNA gene for pathogenic variants associated with periventricular nodular heterotopia (PVNH), an X-linked dominant disorder causing epilepsy and cog...	Peripheral whole blood (venous or finger-prick FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FLNA gene sequence", "Copy Number Variations (CNVs) in FLNA"] Parameters [] Preparation ["No fasting required", "Stay hydrated", "Have Emirates ID ready"] Indications ["Suspected periventricular nodular heterotopia (PVNH)", "Family history of PVNH", "Drug-resistant epilepsy with neurological abnormalities", "Cascade testing for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 92632-0 ICD-10: Q04.8 Clinical summary This genetic test evaluates the FLNA gene for pathogenic variants associated with periventricular nodular heterotopia (PVNH), an X-linked dominant disorder causing epilepsy and cognitive impairment.
TEST-4489 FLNA Gene Periventricular Nodular Heterotopia, Ehlers‑Danlos Variant (PNH‑ED) Genetic Test This test evaluates the FLNA gene for pathogenic variants associated with periventricular nodular heterotopia (PNH) and Ehlers-Danlos-like features.	Peripheral Whole Blood	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FLNA gene sequence", "Pathogenic variants", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Avoid recent trauma or acute febrile illness"] Indications ["Diagnosis of PNH", "Diagnosis of FLNA-related Ehlers-Danlos syndrome", "Family history of FLNA-related disorders", "Carrier screening", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Q04.8 Clinical summary This test evaluates the FLNA gene for pathogenic variants associated with periventricular nodular heterotopia (PNH) and Ehlers-Danlos-like features.
TEST-5704 FLRT1 Genetic Testing (SPG68) Test This test identifies pathogenic variants in the FLRT1 gene, which are responsible for causing autosomal recessive spastic paraplegia type 68 (SPG68). It analyzes the entire coding...	Whole Blood or Extracted DNA	3–4 Weeks (21–28 Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FLRT1 gene sequence", "Coding exons and flanking intronic regions", "Point mutations", "Small insertions or deletions", "Copy number variations"] Parameters [] Preparation ["Avoid non-essential supplementation for 48 hours beforehand", "Maintain normal hydration", "Discuss temporary pause of anticoagulant therapy with doctor 24 hours prior", "Inform phlebotomist of active infections or bleeding concerns"] Indications ["Suspected hereditary spastic paraplegia type 68 (SPG68)", "Individuals with progressive lower-limb spasticity", "Family history supporting recessive inheritance"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G11.4 Clinical summary This test identifies pathogenic variants in the FLRT1 gene, which are responsible for causing autosomal recessive spastic paraplegia type 68 (SPG68). It analyzes the entire coding region and flanking areas of the gene.

Category overview

Neurological Genetics: overview

Securing a deep, fundamental understanding of your family's neurological blueprint allows for proactive, highly informed medical decisions that protect your long-term cognitive and motor vitality. As the core of our advanced neuro-diagnostic laboratory services, the Neurological Genetics department utilizes state-of-the-art sequencing and targeted DNA analysis to uncover the precise genetic mutations driving rare brain, spinal cord, and peripheral nerve diseases. By leveraging advanced molecular technology, this expansive profiling helps establish an absolute diagnosis for elusive conditions, safely guiding your healthcare provider in tailoring highly personalized precision medicine, supportive therapies, and proactive family planning. Trusted for clinical rigor across premier diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical accuracy, and incredibly prompt turnaround times. Take an empowered step toward targeted neurological support—schedule your neurological genetics testing in UAE, coordinate a seamless clinic or home sample collection, or connect with our specialized specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.